Co-construction of Biological and Molecular Medicine Research Institute by JITRI, Harbour BioMed and Kunshan High-tech Zone
In order to introduce global antibody research and development technology, JITRI, Harbour BioMed and Kunshan High-tech Zone jointly established Biological and Molecular Medicine Research Institute on August 10, 2017 to upgrade bio-medicine industry in Jiangsu. This institute is the 13th one newly built on the basic of Project Manager System, which means there are 36 specialized institutes under JITRI umbrella.
In recent years, biological medicine research has full access to time of antibody drugs which is the important opportunity of Chinese bio-medicine industry development. As the propeller of industry transformation and upgrading, JITRI holds an important position to promote industry innovative development. So, JITRI bonded with Harbour BioMed and Kunshan High-tech Zone took the lead in the bio-medicine industry layout and introduced Harbour BioMed’s excellent medicine research team and core technology platform. Based on the advantages of bio-medicine clusters in Kunshan, this institute will forge world-leading R&D platform to support biological and molecular medicine industry development.